Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation of MQ Holding’s first quarter results 2018/2019

MQ Holding will announce its first quarter results (September 2018 – November 2018) on Tuesday, December 18th at 07.15 CET. A telephone conference will be held on the same day for analysts, investors and media at 09:00 CET. Ingvar Larsson, President and CEO and Tony Siberg, EVP and CFO will present and comment on the report and the latest developments in MQ Holding. The presentation will be held in Swedish. The presentation can also be followed via audio cast on www.mq.se . It is possible to listen to the audio cast afterwards at the same place. To participate in

Sectra enters the South Korean market by signing digital pathology distribution agreement with HuminTec

Linköping, Sweden – December 4, 2018 –  International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has entered into a partnership with HuminTec, a leading software company in the field of pathology in South Korea. Through the distribution agreement, the South Korean healthcare market will gain access to Sectra’s digital pathology solution. This solution supplies healthcare providers with digital management of microscopic images, which contributes to improved efficiency and quality of cancer care.“South Korea is the third largest economy in East

CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery

Scientists will work side-by-side in MedImmune labs, aiming to speed research and development of new therapies CELLINK, focused on the development and commercialization of innovative bioprinting technologies, announced today that the company will enter a year-long collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, providing 3D-Bioprinted tissues to aid in the exploration of new disease targets in MedImmune’s core therapeutic areas, including oncology, respiratory, and cardiovascular, renal and metabolic diseases. The collaboration will

Helsinki’s top-rated startup ecosystem boosted by construction of Maria 01, one of Europe's largest Startup Campuses

Photo: AOR Architects Helsinki is developing an internationally significant Startup Campus with around 5,000 jobs and 70,000 square metres in connection to the successful Maria 01 startup hub. The new Maria 01 campus will be looking to attract growth companies, startups, anchor companies, investors, accelerators and representatives of research and development activities. The objective is to get around 650 new actors in addition to the current 130 actors. The global startup community's interest in Helsinki is continuously growing. "During the expansion project, Maria 01 will

Reduced corporate tax rate on Norwegian operations

The Norwegian parliament (Stortinget) has formally approved the state budget for 2019.  In the budget, the corporate tax rate in Norway has been reduced from 23% to 22%.The change in the tax rate will reduce the tax expense to be incurred by Atea in its Norwegian subsidiaries from 2019.At the same time, the change in the tax rate reduces the value of Atea's tax -loss carryforwards in Norway, which are recognized in the balance sheet as deferred tax assets.As of 31/12/2017, Atea had NOK 472 million in deferred tax assets in its Norwegian operations. The reduction in the tax rate

Swedish railway operator SJ will educate its staff in Virtual Reality developed by Bublar Group

Stockholm, SWEDEN — December 4th, 2018 — Vobling AB, a wholly owned subsidiary of Bublar Group AB (publ) (BUBL MTF), a publicly listed Augmented Reality (AR) studio, has in collaboration with the Swedish railway operator SJ developed an educational Virtual Reality (VR) platform and learning experiences focused on the coming upgraded X2000 trains. SJ has now assigned Vobling to further develop the VR platform and a number of new learning experiences covering multiple train models in its fleet. Using the VR platform, the intention is that employees will be educated in areas such as

November: Monthly statistics

The number of customers at Avanza has during 2018 increased by 119,000, amounting to 9,200 new customers in November. This resulted in 829,700 customers at the end of the month. Net inflow in November was SEK 2,730*m, amounting to SEK 26,700*m during 2018.In November, the Swedish Savings Barometer was published with statistics for the third quarter 2018. Avanza's share of the savings market increased to 4.0 per cent at the end of the quarter and the share of net inflow was 16.5 per cent. Rolling 12M net inflow amounted to 11.0 per cent, which exceeds the target of at least 10 per cent.

Anders Lindqvist new President and CEO of Mycronic

Mycronic’s Board of Directors has appointed Anders Lindqvist as new President and CEO of Mycronic. His most recent position was at Piab Group, where he has been CEO since 2013. Anders also has more than 20 years of experience from a number of international managerial positions at Atlas Copco and is originally a mechanical engineer with additional studies in marketing from the University of California. Anders Lindqvist will take up his new position as President and CEO of Mycronic not later than the second quarter of 2019 and will replace Lena Olving, who is retiring. “I am delighted to

Change in number of shares in BrainCool AB (publ)

Conversion of convertible notes into shares, as part of the financing agreement announced 24 August 2018.The number of convertible notes converted on December 3, 2018, was 15. The number of convertible notes remaining under the second tranche for future conversion is 15. The reason is that the conversion of 2 MSEK which was communicated on October 22, 2018, and referring to tranche 1, was changed to tranche 2 for administrative reasons. Therefore, 2.5 MSEK remains in tranche 1. The number of shares and the number of votes before the conversion was 36 830 745. Through this conversion, and

Skanska awarded facilities management contract in the UK worth GBP 196 M, about SEK 2.3 billion

Skanska UK has been awarded a contract by Eastbury Park Limited to provide facilities management services to the Ministry of Defence at Northwood HQ in Hertfordshire. The contract is worth GBP 196 M, about SEK 2.3 billion over a 13-year period. The two-year order value, booked in quarter four 2018, is GBP 47 M, about SEK 550 M.Under a private finance initiative, Skanska UK will deliver all non-military support activities on the site until 2031. Skanska is one of the leading development and construction companies in Europe. Outside the Nordics the company has European operations in

Apetit Plc: Announcement of conveyance of own shares

Apetit Plc, Stock Exchange Release, 4 December 2018 at 9:30 a.m.Apetit Plc has assigned a total of 5.471 shares (APETIT) on 4 December 2018 (other conveyance) as a reward to members of the Board of Directors. The assignment value is EUR 53.290,28 in total, which corresponds approximately to EUR 9.74 per share. Taking into account the above-specified conveyances, the company holds a total 105.955 shares. Apetit Plc’s Supervisory Board decided in April 16, 2018, that the Chairman will receive an annual remuneration of EUR 39,060, the Deputy Chairman will receive EUR 24,120 and the Board

Indutrade’s Capital Markets Day 2018

Indutrade is today hosting a Capital Markets Day in Kista, Sweden. At the Capital Markets Day, information provided previously will be commented on and presented in more depth and detail. Participants will be given an update on Indutrade’s business model and strategy for profitable growth. CEO Bo Annvik and other members of the Management Team will elaborate on strategic initiatives to increase value creation and business performance. Presentations will also cover Indutrade’s operating model, acquisition strategy and way of working. Indutrade’s overall strategic direction is to

Affibody Announces Option Exercise by Biotest

Solna, Sweden, December 4, 2018. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing a portfolio of innovative drug projects, today announced that its partner Biotest, a Germany-based biotherapeutic company, has exercised an option under the two companies’ ongoing collaboration.“Biotest has finalized the research phase of the research license and option agreement we originally signed in 2015 and based on the preclinical results decided to exercise its option. Biotest now receives exclusive rights for further development and commercialization of an innovative new

Biovica establishes office in Boston

Biovica opens an office in Boston, the first office in the US. Pontus Nobréus, Business Development Director, will be heading up the office and will be based in Boston from 1st of January 2019.The office will be located in west Boston. The location is chosen since Boston is an important biotech hub in the US with Biovica collaboration partners, such as Dana Farber Cancer Institute, in the nearby area. USA is the single largest market for Biovica and, most important market. Biovica has previously started a US subsidiary in order to operate in the United States. It is important for us that

Breakthrough for Magic-as-a-Service in North America and general strengthening of cash flows

Realfiction Holding AB (“Realfiction”) announces that the company has received four individual Magic-as-a-Service (MaaS) orders in North America covering Mixed Reality solutions for four premium events in New York, Miami, Las Vegas and Toronto. With these orders, Realfiction and MaaS are gaining significant momentum in North America.With its MaaS concept, Realfiction is offering a full-service Mixed Reality solution including everything from rental and installation of the hardware to original 3D content with periodic over-the-air updates for a fixed monthly fee. It has already gained

OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market.[Recipharm20OnDosis] The new treatment for the management of ADHD will be developed by Recipharm’s Centre of Excellence in Oral Solids and will leverage OnDosis’ proprietary technology which integrates oral drugs in form of micro units and individualised dosing, in a handheld device. The advantages are simplified titration, more accurate dosing and the ability to track

MTG backs premiere gaming and interactive entertainment start-ups

MTG has funded 11 fast-growing companies  that bring strategic value to the Group’s owned and operated esports and online gaming businesses. This makes MTG one of the most active investors in the gaming sector, with a broad portfolio of content, tools and live experiences.· MTG has invested in 11 high-potential US and European gaming businesses since announcing its dedicated gaming fund in November 2017 · Investees include innovative online gaming and esports companies, as well as virtual reality experiences · The investment fund complements

OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market. The new treatment for the management of ADHD will be developed by Recipharm’s Centre of Excellence in Oral Solids and will leverage OnDosis’ proprietary technology which integrates oral drugs in form of micro units and individualised dosing, in a handheld device. The advantages are simplified titration, more accurate dosing and the ability to track dosing and

Strong interest in sales start of affordable row houses in Nedersta

The recent start of sales by Bonava of row houses in Nedersta, Västerhaninge south of Stockholm, was met with strong interest from customers. As many as 25 homes were reserved shortly after the first viewing. This phase of the development comprises a total of 58 row houses and semi-detached houses of between 92 and 123 square metres.- I am delighted with the strong interest shown in our row houses in Nedersta. The project is further evidence that we are successful in our strategic direction. Our defined building systems and efficient internal processes enable us to offer affordable row

STRONG RESULT IN LINE WITH OUTLOOK

AUGUST 2018–OCTOBER 2018 · Revenue: MSEK 12,678 (11,644) · Earnings before tax and nonrecurring items: MSEK 842 (1,054) · EBT: MSEK 809 (657) · Net income for the period: MSEK 640 (490) · Earnings per common share: SEK 1.60 (1.22) · SAS expects to deliver a positive result before tax and nonrecurring items in fiscal year 2019  COMMENTS BY THE PRESIDENT AND CEO OF SAS: More than 30 million passengers traveled with SAS during fiscal year 2018, which is more than any other previous year. This shows that our strategy continues to deliver results.  For further

Skanska sells Bergskvadraten development project in Norrköping, Sweden, for about SEK 490 M

Skanska divests Bergskvadraten development project in Norrköping, Sweden, to Rikshem for about SEK 490 M. The block contains 101 apartments with garage and 72 nursing homes. The project is developed by Skanska Sweden. The divestment will be recorded in the business streams Commercial Property Development and Residential Development in the fourth quarter 2018. The transfer is scheduled for the third quarter 2021.The construction contract, worth about SEK 300 M, was awarded to Skanska Sweden and booked in Q3, 2018. The houses will be built with between two and seven floors with split-level

Samhällsbyggnadsbolaget i Norden AB presents new financial and operational targets

In conjunction with Samhällsbyggnadsbolaget i Norden (publ)’s (”SBB”) Capital Market Day, the company today presents new financial and operational goals adopted by the Board. The goals are presented with a view to give the capital market an updated picture of the company's future direction. SBB's new financial targets (previous levels are given in brackets below): -          Generate growth in net asset value per ordinary share, excluding dividends on ordinary shares, to average at least 12 percent per year over a 5-year period (unchanged) -          Loan to value ratio below 55

Storytel launching service in Bulgaria

In announcing its purchase of Bulgarian audio-book service D&D Factory on September 19th, Storytel made public its intention of providing its streaming service in that country. Today Storytel’s goes online in Bulgaria, its fifteenth market.“Streaming services for film and music are making strong headway in Bulgaria, and we’re interested in getting involved in that development at an early stage. We have a long list of titles, everything from bestsellers to classics to non-fiction, in both Bulgarian and English,” says Stefan Tegenfalk, Head of Expansion. “We’re constantly increasing our

Additional product patent in the United States for HyNap-Dasa

STOCKHOLM, SWEDEN – December 4, 2018. Xspray Pharma AB (Nasdaq First North: XSPRAY) (“Xspray” or the “Company”) announces that the United States Patent and Trademark Office (USPTO) today has granted a new patent in the United States to Xspray. The new patent, US 10,143,683, covers the pharmaceutical composition of Xspray’s lead product candidate, HyNap-Dasa. This is Xspray’s third product patent in the US which is Xspray’s main market. The new patent will expireJanuary 11, 2033.“This new patent approval in our most important market further confirms our innovative development work. Together

There are no items matching the current filter
There are no more items matching the current filter
Back to top